Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?

There is a significant opportunity to improve cardiovascular disease (CVD) outcomes in lung cancer screening cohorts with a low-cost, noninvasive assessment of CVD risk, alongside existing assessments https://bit.ly/3a6Ha41

Detalles Bibliográficos
Autores principales: Guariglia, Andrea, Davies, Iona J., Kanellakis, Nikolaos I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792827/
https://www.ncbi.nlm.nih.gov/pubmed/33447290
http://dx.doi.org/10.1183/20734735.0204-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792827/
https://www.ncbi.nlm.nih.gov/pubmed/33447290
http://dx.doi.org/10.1183/20734735.0204-2020

Ejemplares similares